Deoxyribonucleotide pools are maintained at levels that support efficient and yet accurate DNA replication and repair. Rad53 is part of a protein kinase regulatory cascade that, conceptually, promotes dNTP accumulation in four ways: (1) it activates the transcription of ribonucleotide reductase subunits by inhibiting the Crt1 repressor; (2) it plays a role in relocalization of ribonucleotide reductase subunits RNR2 and RNR4 from nucleus to cytoplasm; (3) it antagonizes the action of Sml1, a protein that binds and inhibits ribonucleotide reductase; and (4) it blocks cell-cycle progression in response to DNA damage, thus preventing dNTP consumption through replication forks. Although several lines of evidence support the above modes of Rad53 action, an effect of a rad53 mutation on dNTP levels has not been directly demonstrated. In fact, in a previous study, a rad53-11 mutation did not result in lower dNTP levels in asynchronous cells or in synchronized cells that entered the S-phase in the presence of the RNR inhibitor hydroxyurea. These anomalies prompted us to investigate whether the rad53-11 mutation affected dNTP levels in cells exposed to a DNA-damaging dose of ethylmethyl sulfonate (EMS). Although dNTP levels increased by 2-to 3-fold in EMS treated wild-type cells, rad53-11 cells showed no such change. Thus, the results indicate that Rad53 checkpoint function is not required for dNTP pool maintenance in normally growing cells, but is required for dNTP pool expansion in cells exposed to DNA-damaging agents. Ó 2006 Elsevier Inc. All rights reserved.Keywords: Rad53; dNTP; DNA damage; RNR; EMS; Yeast Cells have evolved mechanisms to maintain or augment deoxyribonucleotide triphosphate levels during DNA synthesis and repair. Yeast cells respond to DNA damage and replication block by arresting the progression of the cell cycle at specific points and by inducing the expression of genes thought to facilitate DNA repair. These responses are mediated by a kinase cascade that appears to be conserved among eukaryotes. Two essential genes, MEC1 and RAD53, are central players in the kinase cascade that leads to cell-cycle arrest at all the checkpoints and transcriptional activation in response to DNA damage. Cells with mutations in the Mec1 or Rad53 genes are defective in both cell-cycle arrest and gene expression responses in response to DNA damage, but retain their essential functions for cell survival under normal conditions [1][2][3][4][5]. Among the best characterized transcriptional targets of the Rad53 kinase cascade are the RNR genes, which encode subunits of ribonucleotide reductase, the enzyme that catalyzes the rate-limiting step in dNTP synthesis [1]. In addition to transcriptional induction of RNR genes, the Rad53 pathway also induces RNR activity through the removal of Sml1, an RNR inhibitor that binds to large subunits and inhibits enzyme activity [6]. Lethality of Rad53 null mutation is suppressed by overexpression of genes encoding ribonucleotide reductase [3] or by deletion of RNR inhibitor Sml1...